Harvard Business Review

OCTOBER 25, 2018

These firms make up two thirds of global corporate pretax earnings (EBTDA) and revenues. The bottom 10% destroy roughly as much economic value as the superstar firms create. But this is also mirrored by firms in the bottom 10%, which account for 1.5 Superstar firms create 1.6 times more economic loss today than 20 years ago.

Industry 10

Industry Company GDP Bottom-up 10

Harvard Business Review

JUNE 26, 2014

You can watch the recording of our conversation at the bottom of this post.). The system works better in the pharmaceutical and chemical industries since the “boundaries” around the patents — what is and isn’t covered — are relatively clear. But ultimately the onus is largely on policymakers to clean up the mess.

Innovation 8

Innovation Pharmaceuticals Chemicals Software 8

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. At Harvard's Edmond J. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. As a group, the largest U.S. In some instances, the end results were firm closures and lost jobs.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

NOVEMBER 29, 2018

It enables knowledge from activities throughout the organization in the previous 24 hours to escalate up to executive leadership — Tier VI in our model — and be addressed. The information that escalates up falls into two categories: Issues that cannot be resolved at a given tier.

Health Care 9

Health Care System Metrics Report 9

Harvard Business Review

MAY 2, 2013

These researchers opined that high prices are preventing patients from being treated, and they questioned the ethics of pharmaceutical companies. This is why Las Vegas hotels, for instance, have premium prices on weekends and rock bottom discounts during the middle of the week. This cost structure enables pricing flexibility.

Discount 8

Discount Price Fixed Costs Pharmaceuticals 8

Harvard Business Review

JANUARY 24, 2012

Nine years ago, when I launched The Energy Project during an economic boom, it was nearly impossible to find senior leaders open to the idea that demand was exceeding people's capacity, and that it was critical to the bottom line to teach employees new ways to manage their energy more skillfully.

Meyer 14

Meyer Goleman Emotional Intelligence Pharmaceuticals 14

Harvard Business Review

SEPTEMBER 13, 2016

The secret to changing an organization is to understand the fundamental units that make up the social system — these local tribes — and to invert the change process so that tribes own the change. ” He asked the 2,400 employees to come up with ideas to save money.

Resistance 8

Resistance Influence Pharmaceuticals Bottom-up 8

Harvard Business Review

MAY 18, 2015

Despite some early warnings, both the regulators and the company did not really follow up the case until it was too late. At this point – the tipping point — companies would hugely benefit if people speak up and use this information to correct the bad decisions they made. billion from a series of high-risk trades.

Compliance 8

Compliance Company Self-aware Ethics 8

Harvard Business Review

SEPTEMBER 19, 2013

Thinking beyond the bottom line was considered unfocused or, even worse, a disservice to shareholders. These “wavemakers” assume many forms, including edgy social enterprises with the mentality of a Silicon Valley start-up, megafoundations, and Fortune 500 companies that now deliver social good on the path to profit.

Pharmaceuticals 10

Pharmaceuticals Marketing Politics Bottom-up 10

Harvard Business Review

FEBRUARY 6, 2014

Moreover, reaching the ultimate level of chief executive is not just another move up the corporate ladder. And what was critical here, in our view, or at any major enterprise for that matter, is for the directors to take the time to watch the candidates in action and to drill down with bottoms up data. Lafley has described it.

CEO 8

CEO Bottom-up Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 11, 2018

This phase involved a round of interviews with people at 28 organizations across a variety of sectors, including aviation, banking, pharmaceutical, professional services, and technology. Phased returns offer “check-in days” during leave and a gradual return that ramps up from three days a week to four, and then to five.

Career 10

Career Company Pharmaceuticals Long-term 10

Harvard Business Review

OCTOBER 8, 2013

Second, unless the job is extremely simple (requiring no creativity, problem-solving, or complex reasoning abilities), monetary rewards can paradoxically impair performance by leading employees to focus too much on the up-coming extra cash. With prosocial bonuses, however, we were able to measure the dollar impact on the bottom line.

Norton 10

Norton Morale Pharmaceuticals Banking 10

Harvard Business Review

JULY 14, 2017

Pharmaceutical company Lilly has said , “Many tragic world events have shaken our employees, making it difficult for them to bring their full selves to work. ” Managers should set the tone by encouraging people to speak up, teaching people how to have difficult conversations , and managing any disagreements on their teams.

Diversity 8

Diversity Politics Survey Incubator 8

Harvard Business Review

JANUARY 31, 2013

Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines. So-called additive manufacturing techniques such as 3D printing, which create objects by combining small particles rather than by casting or stamping, open up all sorts of possibilities. but also the risks.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

NOVEMBER 15, 2018

An investor-owned hospital executive whose company had acquired major nonprofit health care enterprises compared the proliferation of contracts to the growth of barnacles on the bottom of a freighter. The growth of these costs rivals those of specialty pharmaceuticals and the maintenance and updating of electronic health record systems.

Cost 9

Cost System Management Franchising 9

Harvard Business Review

DECEMBER 5, 2016

We believed that if the Library was to be truly nimble, senior leaders couldn’t unilaterally come up with a plan. The conversation would be neither bottom-up nor top down. Japanese pharmaceutical Eisai used them to improve care for Alzheimer’s patients. in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

FEBRUARY 20, 2014

As collectibles go, magazines are at the bottom of the list. Why bring up an article in a dusty old magazine? If it were up to me, I’d put more resources into space exploration.) It’s not inconceivable that in the not-too-distant future, China will catch up with us in space. I just don’t buy it.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

SEPTEMBER 5, 2013

One of us (Jordan) had personal responsibility for setting up such a service in Pfizer - it became known as PfizerWorks, and its aim was simply to help employees be more effective in their jobs. Now whenever a PfizerWorks user decides she needs support, she simply pushes a button, describes her need in a pop-up window, and presses send.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

FEBRUARY 4, 2013

Breakthrough requires an end to systemic inequities by opening up processes, information - and markets. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Accelerating Customer Adoption at the Bottom of the Pyramid. Breakthrough Access. Scaling Social Impact Insights from HBR and the Bridgespan Group.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

DECEMBER 27, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). Employees and community were at the bottom. Gerstner Jr. headed the company, he orchestrated an epic turnaround, putting shareholder value and customer satisfaction at the top of the list.

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

APRIL 22, 2013

How does a man garner the courage to act, despite these worries, and get his boss and co-workers to encourage him to have breakfast with his family, leave in time to pick up kids at school, and be truly focused on his family when he''s with them instead of constantly checking his digital device about work matters?

Delegation 8

Delegation Commitment Learning-by-Doing Bottom-up 8

Harvard Business Review

NOVEMBER 25, 2015

In a recent strategy meeting we attended with the leaders of a Fortune-500 company, the word “culture” came up 27 times in 90 minutes. In this article, we address each of these to show how leaders can engineer high-performing organizational cultures — and measure their impact on the bottom line. DAVE WHEELER FOR HBR.

Motivation 8

Motivation Company Airlines Learning-by-Doing 8

Harvard Business Review

SEPTEMBER 3, 2013

Hilde Dach, the former chief scientist at drug-development start-up Genbac and now a team leader at German pharmaceuticals maker Caliska, which had acquired Genbac, could read disappointment in the face of Johan Greve, the Caliska division head who was her boss. We can get them up," she said encouragingly. "It Hilde turned away.

Case Study 8

Case Study Pharmaceuticals Bottom-up Marketing 8

Strategy Driven

JANUARY 24, 2011

OnPoint Consulting’s 2010 Execution Gap Maker Round-Up… Execution Gap Maker #1: BP (Need I say more?) Leading up to and after the oil spill BP violated almost all the guidelines of effective execution, including lacking an effective structure and lacking clear accountability. More like a chasm, really.)

Execution 78

Execution Company 360-Degree Feedback Cooper 78

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Taylor created a sense of urgency and then kept up the pace with tight deadlines. Embrace speed at every possible juncture.

Middle Management 11

Middle Management Six Sigma Taylorism Taylor 11

Harvard Business Review

APRIL 19, 2016

In the pharmaceutical industry, the monitoring process can be incredibly elaborate. I would also think seriously about geography and build up relationships with universities in your area that you can drop in on and interact with.” ” Bridge the cultural divide. ” We need to move faster.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

OCTOBER 26, 2017

Two decades later, an incredible tool is shoring up the foundations of social at the level of every transaction—blockchain. A blockchain could record registered attestations important for supply chain participants, producers, and consumers, including ensuring source farms use sustainable practices and live up to fair trade practices.

Supply Chain 8

Supply Chain Content Power Transportation 8

Harvard Business Review

SEPTEMBER 12, 2014

Over the past few years, Soon-Shiong has been putting together a company that he hopes will be positioned to take us into health care’s tech-heavy future, with computers sequencing genomes, helping doctors monitor hundreds of patients at a time, and providing up-to-date information on which treatments are best.

Performance Review 9

Performance Review Review Quinn Health Care 9

Harvard Business Review

SEPTEMBER 11, 2014

have increased by 6x (from 100k to 600k annually) and, worldwide, start-ups have increased from 10 million to almost 100 million per year. For example, when Rent the Runway founder Jenn Hyman came up with the idea to rent designer dresses over the internet , demand uncertainty was high because no one else was offering this type of service.

Uncertainty 20

Uncertainty Industry Bottom-up Technology 20

Harvard Business Review

JUNE 20, 2017

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards. The bottom line is, multinationals will not know what will be in the final agreement for years.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

FEBRUARY 24, 2017

Holding up a bill in committee or working with others to stall legislation may be difficult to tie to any single person, while other actions can be defended on alternative premises , like coincidence (the idea that conflicts are inevitable among the myriad issues facing Congress) or even that they are based on a stockbroker’s advice.

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8